Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 1.1 Exhibit 1.1
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.3 Exhibit 4.3
- 4.4 Exhibit 4.4
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 5.1 Exhibit 5.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 14.1 Exhibit 14.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
AKL similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Subsidiaries of Akela Pharma Inc.
As of August 31, 2007
State of Incorporation | Name of Subsidiary/Affiliate | Percent of Voting Securities Owned as of August 31, 2007 | |||
---|---|---|---|---|---|
Delaware | LAB Pharma International LLC | 100 | |||
Finland | LAB Pharma Oy | 100 | |||
Quebec, Canada | 4349695 Canada Inc. | 100 | |||
Delaware | LAB Pharma USA Corporation | 100 | |||
Texas | Formulation Technologies LLC | 100 | |||
Barbados | LAB International SRL | 100 | * | ||
Quebec, Canada | 4273567 Canada Inc. | 100 |
- *
- Akela Pharma Inc. directly owns 99% of the outstanding shares of LAB International SRL and LAB Pharma International LLC owns the remaining 1%.